Navigation Links
Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles
Date:3/21/2010

icle dose administered to the patient, the higher the number of particles found inside the tumor cellsthe first example of this kind of dose-dependent response using targeted nanoparticles.

Even better, Davis says, the evidence showed the siRNAs had done their job. In the tumor cells analyzed by the researchers, the mRNA encoding the cell-growth protein ribonucleotide reductase had been degraded. This degradation, in turn, led to a loss of the protein.

More to the point, the mRNA fragments found were exactly the length and sequence they should be if they'd been cleaved in the spot targeted by the siRNA, notes Davis. "It's the first time anyone has found an RNA fragment from a patient's cells showing the mRNA was cut at exactly the right base via the RNAi mechanism," he says. "It proves that the RNAi mechanism can happen using siRNA in a human."

"There are many cancer targets that can be efficiently blocked in the laboratory using siRNA, but blocking them in the clinic has been elusive," says Antoni Ribas, associate professor of medicine and surgery at UCLA's Jonsson Comprehensive Cancer Center. "This is because many of these targets are not amenable to be blocked by traditionally designed anti-cancer drugs. This research provides the first evidence that what works in the lab could help patients in the future by the specific delivery of siRNA using targeted nanoparticles. We can start thinking about targeting the untargetable."

"Although these data are very early and more research is needed, this is a promising study of a novel cancer agent, and we are proud of our contribution to the initial clinical development of siRNA for the treatment of cancer," says Anthony Tolcher, director of clinical research at South Texas Accelerated Research Therapeutics (START).

"Promising data from the clinical trials validates our years of research at City of Hope into ribonucleotide reductase as a target for novel gene-based therapies for
'/>"/>

Contact: Jon Weiner
jrweiner@caltech.edu
626-395-3226
California Institute of Technology
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Caltech-led researchers find negative cues from appearance alone matter for real elections
2. ARS study provides a better understanding of how mosquitoes find a host
3. Seafarers scourge provides hope for biofuel future
4. March of Dimes provides $2.6 million in new funding for preterm birth research
5. A deadly scorpion provides a safe pesticide
6. Study provides insight into pathway linked to obesity
7. Sweet corn study provides large-scale picture of better fields
8. BIO-key(R) Provides Update to Special Shareholder Meeting
9. New research provides insights into potential ecological costs and cobenefits of REDD
10. ERC provides millions for biodiversity research
11. Joint US-Norwegian study provides new insights into marine ecosystems and fisheries production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles
(Date:7/11/2014)... have set a "mouse TRAP" to capture the early ... study published in the Journal of Clinical Investigation ... called TRAP to extract cellular and genetic information from ... at the Rockefeller Institute for Medical Research in 2008, ... machinery, or ribosomes, of the cell type of interest. ...
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
(Date:7/11/2014)... Researchers from Ume University, Sweden, have explored two ... the reaction sequence leading to the formation of ... been published in the scientific journal Nature ... improving present day synthetic catalysts for water oxidation, ... devices for the direct storage of solar energy ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Molecular snapshots of oxygen formation in photosynthesis 2
... millipedes previously unknown in Australia has been discovered by ... of the widespread tropical family Pyrgodesmidae have been found among ... are not only widespread in Australia,s tropical and subtropical ... been published in the open access journal ZooKeys ...
... Trust and the Engineering and Physical Sciences Research Council ... initiative to find biomedical engineering solutions to challenging healthcare ... provide funding for a limited number of ground-breaking long-term ... are inadequate. Up to 10m over seven years is ...
... 29, 2012 The Crop Science Society of America (CSSA) ... during their Annual Meetings, Oct. 21-24, 2012 in Cincinnati, OH. ... professional achievements and meritorious service. Only 0.3 percent of the ... 2012 class of CSSA Fellows are: Marc C. ...
Cached Biology News:Millipede family added to Australian fauna 2£30 million boost for biomedical engineering research 2Crop Science Society of America presents 2012 class of fellows 2Crop Science Society of America presents 2012 class of fellows 3
(Date:7/11/2014)... , July 11, 2014 Research and ... Transfection Technology Market - Global Industry Analysis, Size, Share, ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... nucleic acids (either DNA or RNA) into cells. This ... of cancer cells and protein metabolism by affecting the ...
(Date:7/11/2014)... 11, 2014  Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/10/2014)... London, UK (PRWEB) July 10, 2014 ... inaugural 21st Century Medicine Forum on ‘Commercialising Longevity ... scientists and entrepreneurs to the London Bioscience Innovation ... Biogerontology Research Foundation and Aging Analytics Ltd. The ... and investment in translational research for age-related disease, ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... -- bioTheranostics, a bioMerieux company that develops ... announced today study results published in the next issue ... to the clinical validity and the clinical utility of ... in the determination of the origin of a tumor. ...
... 2011 Peloton Therapeutics, Inc., an early-stage cancer drug ... an $18 million Series A financing.  Led by The ... O,Donnell, Jr., the Series A funds supplement a recently ... Research Institute of Texas (CPRIT). Peloton officials ...
... 2011 The Raymond and Ruth Perelman ... announces the launching of a first-of-its-kind interdisciplinary ... diseases. The Center will bring together, without institutional ... orphan diseases: establishing dedicated research support facilities, translating ...
Cached Biology Technology:New Study Reports CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility 2New Study Reports CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility 3Peloton Therapeutics Completes $18 Million Series A Financing 2Peloton Therapeutics Completes $18 Million Series A Financing 3Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy 2
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
Biology Products: